iKang Healthcare Group, Inc. (KANG) Upgraded to Sell by BidaskClub
BidaskClub upgraded shares of iKang Healthcare Group, Inc. (NASDAQ:KANG) from a strong sell rating to a sell rating in a research report sent to investors on Saturday morning.
Shares of iKang Healthcare Group (NASDAQ KANG) traded up 3.45% during midday trading on Friday, hitting $13.80. 531,529 shares of the stock were exchanged. iKang Healthcare Group has a 12 month low of $11.70 and a 12 month high of $19.23. The company’s market cap is $890.79 million.
iKang Healthcare Group (NASDAQ:KANG) last posted its quarterly earnings results on Thursday, June 22nd. The medical research company reported ($0.49) EPS for the quarter. The company had revenue of $60.16 million during the quarter. iKang Healthcare Group had a negative return on equity of 3.19% and a negative net margin of 2.58%. On average, equities analysts anticipate that iKang Healthcare Group will post $0.65 earnings per share for the current year.
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. First Manhattan Co. increased its position in iKang Healthcare Group by 101.7% in the second quarter. First Manhattan Co. now owns 1,040,043 shares of the medical research company’s stock valued at $12,761,000 after buying an additional 524,318 shares in the last quarter. Athos Capital Ltd bought a new position in iKang Healthcare Group during the second quarter valued at approximately $8,622,000. Finally, SG Americas Securities LLC increased its position in iKang Healthcare Group by 14.6% in the second quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock valued at $547,000 after buying an additional 5,700 shares in the last quarter. 29.79% of the stock is currently owned by institutional investors.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.
Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.